What does Enveric Biosciences, Inc. do?
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental…
What is Enveric Biosciences, Inc.'s P/E and P/B ratio?
Enveric Biosciences, Inc. has a P/E ratio of -0.1 and a P/B ratio of 0.81.
What is Enveric Biosciences, Inc.'s debt-to-equity ratio?
Enveric Biosciences, Inc. has a debt-to-equity ratio of 0.00.
How much does Enveric Biosciences, Inc. owe compared with what it owns?
Enveric Biosciences, Inc. owes $0.10 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Enveric Biosciences, Inc.'s Positivity rank?
Enveric Biosciences, Inc. is ranked #2,356 of 6,774 companies globally and #727 of 4,000 in United States on PositoAI, with a Positivity Score of 21,600.
Does Enveric Biosciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Enveric Biosciences, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 23 Oct 2025). It has no yellow flags.
Where can I read the latest news about Enveric Biosciences, Inc.?
Recent headlines about Enveric Biosciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Enveric Biosciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Enveric Biosciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.